Intergroup Randomized Phase III Study of Postoperative Oxaliplatin, 5‐Fluorouracil, and Leucovorin Versus Oxaliplatin, 5‐Fluorouracil, Leucovorin, and Bevacizumab for Patients with Stage II or III Rectal Cancer Receiving Preoperative Chemoradiation: A Trial of the ECOG‐ACRIN Research Group (E5204)
Chakravarthy, A. Bapsi, Zhao, Fengmin, Meropol, Neal J., Flynn, Patrick J., Wagner, Lynne I., Sloan, Jeffrey, Diasio, Robert B., Mitchell, Edith P., Catalano, Paul, Giantonio, Bruce J., Catalano, Robert B., Haller, Daniel G., Awan, Rashid A., Mulcahy, Mary F., O'Brien, Timothy E., Santala, Roger, Cripps, Christine, Weis, John R., Atkins, James N., Leichman, Cynthia G., Petrelli, Nicholas J., Sinicrope, Frank A., Brierley, James D., Tepper, Joel E., O'Dwyer, Peter J., Sigurdson, Elin R., Hamilton, Stanley R., Cella, David, Benson, Al B.
Published in The oncologist (Dayton, Ohio) (01.05.2020)
Published in The oncologist (Dayton, Ohio) (01.05.2020)
Get full text
Journal Article
Differential sensitivity to imatinib of 2 patients with metastatic sarcoma arising from dermatofibrosarcoma protuberans
Maki, Robert G., Awan, Rashid A., Dixon, Richard H., Jhanwar, Suresh, Antonescu, Cristina R.
Published in International journal of cancer (20.08.2002)
Published in International journal of cancer (20.08.2002)
Get full text
Journal Article